{"id":238,"date":"2026-05-25T02:09:40","date_gmt":"2026-05-25T02:09:40","guid":{"rendered":"https:\/\/easlfibronostg.wpenginepowered.com\/?page_id=238"},"modified":"2026-06-21T13:48:20","modified_gmt":"2026-06-21T13:48:20","slug":"publications","status":"publish","type":"page","link":"https:\/\/fibronostics.com\/?page_id=238","title":{"rendered":"Publications"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"238\" class=\"elementor elementor-238\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-58683b3 e-flex e-con-boxed e-con e-parent\" data-id=\"58683b3\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0ef8cce elementor-widget elementor-widget-heading\" data-id=\"0ef8cce\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Publications<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7a9ab75 e-flex e-con-boxed e-con e-parent\" data-id=\"7a9ab75\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e9320fa elementor-widget elementor-widget-heading\" data-id=\"e9320fa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Publications Highlight<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5daf291 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"5daf291\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Highlights<\/h2>\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6ae6c42 e-con-full e-flex e-con e-child\" data-id=\"6ae6c42\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-e0fbac0 e-con-full e-flex e-con e-child\" data-id=\"e0fbac0\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1f2661e elementor-widget elementor-widget-image\" data-id=\"1f2661e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=287\" target=\"_blank\">\n\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"657\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-1024x657.png\" class=\"attachment-large size-large wp-image-368\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-1024x657.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-300x193.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-768x493.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-1200x770.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-1400x899.png 1400w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM.png 1424w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6a4a8e6 elementor-widget elementor-widget-heading\" data-id=\"6a4a8e6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Dynamics of Noninvasive Tests (NITs) \u2013 LIVERFASt, FIB-4 and Vibration-Controlled Transient Elastography (VCTE, FibroScan), During Monitoring Therapy with Resmetirom (RT) in Patients with MASH<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b45845a e-con-full e-flex e-con e-child\" data-id=\"b45845a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-33cabe7 elementor-widget elementor-widget-image\" data-id=\"33cabe7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=289\" target=\"_blank\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"655\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1024x655.png\" class=\"attachment-large size-large wp-image-369\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1024x655.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-300x192.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-768x491.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1536x982.png 1536w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1200x767.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1400x895.png 1400w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM.png 1614w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2307e2d elementor-widget elementor-widget-heading\" data-id=\"2307e2d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">LIVERFASt Outperforms FIB-4, in Sequential Combination with Vibration-Controlled Transient Elastography (VCTE) for Identifying \u2265F3 Stages in Patients with MASLD Including Patients with Type 2 Diabetes (T2DM)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-628ab08 e-flex e-con-boxed e-con e-parent\" data-id=\"628ab08\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-c4cabf5 e-con-full e-flex e-con e-child\" data-id=\"c4cabf5\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b7b45cb elementor-widget elementor-widget-heading\" data-id=\"b7b45cb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Publications<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0a2fe84 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"0a2fe84\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Read our selected <span style=\"color: #1A7497\"><i>publications<\/i><\/span><\/h2>\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-766a080 e-con-full e-flex e-con e-child\" data-id=\"766a080\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-fc4d935 e-grid e-con-full e-con e-child\" data-id=\"fc4d935\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-25dfeef e-con-full e-flex e-con e-child\" data-id=\"25dfeef\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c135005 elementor-widget elementor-widget-image\" data-id=\"c135005\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=365\" target=\"_blank\">\n\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"657\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-1024x657.png\" class=\"attachment-large size-large wp-image-368\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-1024x657.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-300x193.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-768x493.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-1200x770.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM-1400x899.png 1400w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.46.00-PM.png 1424w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-16ba8d1 e-con-full e-flex e-con e-child\" data-id=\"16ba8d1\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-775d6b5 elementor-widget elementor-widget-heading\" data-id=\"775d6b5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Dynamics of Noninvasive Tests (NITs) \u2013 LIVERFASt, FIB-4 and Vibration-Controlled Transient Elastography (VCTE, FibroScan), During Monitoring Therapy with Resmetirom (RT) in Patients with MASH<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5a2291d e-con-full e-flex e-con e-child\" data-id=\"5a2291d\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cf0bb91 elementor-widget elementor-widget-image\" data-id=\"cf0bb91\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=366\" target=\"_blank\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"655\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1024x655.png\" class=\"attachment-large size-large wp-image-369\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1024x655.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-300x192.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-768x491.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1536x982.png 1536w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1200x767.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM-1400x895.png 1400w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-06-21-at-9.47.13-PM.png 1614w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-622b5de e-con-full e-flex e-con e-child\" data-id=\"622b5de\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-acc8ba0 elementor-widget elementor-widget-heading\" data-id=\"acc8ba0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">LIVERFASt Outperforms FIB-4, in Sequential Combination with Vibration-Controlled Transient Elastography (VCTE) for Identifying \u2265F3 Stages in Patients with MASLD Including Patients with Type 2 Diabetes (T2DM)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6dd3031 e-con-full e-flex e-con e-child\" data-id=\"6dd3031\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-86ddc67 elementor-widget elementor-widget-image\" data-id=\"86ddc67\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=349\" target=\"_blank\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"514\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-txwt-1024x514.png\" class=\"attachment-large size-large wp-image-351\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-txwt-1024x514.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-txwt-300x151.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-txwt-768x386.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-txwt-1536x772.png 1536w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-txwt-2048x1029.png 2048w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-txwt-1200x603.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-txwt-1400x703.png 1400w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a93ac08 e-con-full e-flex e-con e-child\" data-id=\"a93ac08\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1059b47 elementor-widget elementor-widget-heading\" data-id=\"1059b47\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Combination of LIVERfASt (LF) &amp; Liver Stiffness Measurement (LSM) using Fibroscanoutperforms FIB-4 &amp; LSM, for the identification of MASLD advanced fibrosis (AF) inpatients with type 2 diabetes (T2D)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-066d629 e-con-full e-flex e-con e-child\" data-id=\"066d629\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4b5f184 elementor-widget elementor-widget-image\" data-id=\"4b5f184\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=348\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"509\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tyee-1024x509.png\" class=\"attachment-large size-large wp-image-352\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tyee-1024x509.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tyee-300x149.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tyee-768x382.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tyee-1536x764.png 1536w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tyee-2048x1018.png 2048w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tyee-1200x597.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tyee-1400x696.png 1400w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d07af31 e-con-full e-flex e-con e-child\" data-id=\"d07af31\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b5f431d elementor-widget elementor-widget-heading\" data-id=\"b5f431d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">LIVERFASt (L-FAST) identifies advanced (F3F4, AF) and clinically significant fibrosis (F2-F4, CSF) especially well with Fibroscan in MASLD patients (pts) from a tertiary hepatology center<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-09d5b89 e-con-full e-flex e-con e-child\" data-id=\"09d5b89\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-94c94fc elementor-widget elementor-widget-image\" data-id=\"94c94fc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=287\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"767\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnhc-1024x767.png\" class=\"attachment-large size-large wp-image-290\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnhc-1024x767.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnhc-300x225.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnhc-768x575.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnhc-1200x899.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnhc-1400x1049.png 1400w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnhc.png 1434w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1423d31 e-con-full e-flex e-con e-child\" data-id=\"1423d31\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b5baf87 elementor-widget elementor-widget-heading\" data-id=\"b5baf87\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Non-invasive initiation and monitoring of the therapy with TNR-beta agonist resmetirom (RT) using LiverFast, FIB-4 and vibration-controlled transient elastography (VCTE, FibroScan) in patients with MASH<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-c357568 e-con-full e-flex e-con e-child\" data-id=\"c357568\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-700e24a elementor-widget elementor-widget-image\" data-id=\"700e24a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=288\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"848\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnzm-1024x848.png\" class=\"attachment-large size-large wp-image-292\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnzm-1024x848.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnzm-300x248.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnzm-768x636.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lnzm.png 1150w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a0fd55d e-con-full e-flex e-con e-child\" data-id=\"a0fd55d\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1668b9b elementor-widget elementor-widget-heading\" data-id=\"1668b9b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">LIVERFASt (L-FAST) identifies advanced (F3F4, AF) and clinically significant fibrosis (F2-F4, CSF) especially well with Fibroscan in MASLD patients (pts) from a tertiary hepatology center<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-87991fe e-con-full e-flex e-con e-child\" data-id=\"87991fe\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ad55e56 elementor-widget elementor-widget-image\" data-id=\"ad55e56\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=353\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"572\" height=\"1024\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_bbi64ubbi64ubbi6-572x1024.png\" class=\"attachment-large size-large wp-image-293\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_bbi64ubbi64ubbi6-572x1024.png 572w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_bbi64ubbi64ubbi6-167x300.png 167w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_bbi64ubbi64ubbi6-300x538.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_bbi64ubbi64ubbi6.png 768w\" sizes=\"(max-width: 572px) 100vw, 572px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4453813 e-con-full e-flex e-con e-child\" data-id=\"4453813\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7eb83b2 elementor-widget elementor-widget-heading\" data-id=\"7eb83b2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b00bb11 e-con-full e-flex e-con e-child\" data-id=\"b00bb11\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7504e97 elementor-widget elementor-widget-image\" data-id=\"7504e97\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=289\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1650\" height=\"1394\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lqds.png\" class=\"attachment-full size-full wp-image-294\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lqds.png 1650w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lqds-300x253.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lqds-1024x865.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lqds-768x649.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lqds-1536x1298.png 1536w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lqds-1200x1014.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-lqds-1400x1183.png 1400w\" sizes=\"(max-width: 1650px) 100vw, 1650px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a7b67be e-con-full e-flex e-con e-child\" data-id=\"a7b67be\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-eb16d37 elementor-widget elementor-widget-heading\" data-id=\"eb16d37\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Comparison of the prevalence of advanced fibrosis (AF) using two combinations\nLiver stiffness measurement (LSM or VCTE Fibroscan) along with LiverSTAT\n(LST) or FIB-4 in a prospective chronic liver diseases (CLD) cohort<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3e82819 e-con-full e-flex e-con e-child\" data-id=\"3e82819\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-de9c58e elementor-widget elementor-widget-image\" data-id=\"de9c58e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=301\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1582\" height=\"1478\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-mttf.png\" class=\"attachment-full size-full wp-image-302\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-mttf.png 1582w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-mttf-300x280.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-mttf-1024x957.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-mttf-768x718.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-mttf-1536x1435.png 1536w\" sizes=\"(max-width: 1582px) 100vw, 1582px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-cfdc241 e-con-full e-flex e-con e-child\" data-id=\"cfdc241\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1b66eaa elementor-widget elementor-widget-heading\" data-id=\"1b66eaa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">The utility of noninvasive tests (NITs) -LIVERFASt, FIB4 and VCTE (Fibroscan) - in the initiation and monitoring of the therapy with TNR-beta agonist (resmetirom) in MASH patients<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-64d1a58 e-con-full e-flex e-con e-child\" data-id=\"64d1a58\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cd72f46 elementor-widget elementor-widget-image\" data-id=\"cd72f46\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=305\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1628\" height=\"1056\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-murc.png\" class=\"attachment-full size-full wp-image-304\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-murc.png 1628w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-murc-300x195.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-murc-1024x664.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-murc-768x498.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260527-murc-1536x996.png 1536w\" sizes=\"(max-width: 1628px) 100vw, 1628px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-78ace2d e-con-full e-flex e-con e-child\" data-id=\"78ace2d\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9629844 elementor-widget elementor-widget-heading\" data-id=\"9629844\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Retrospective cross sectional evaluation of the LIVERFASt Test for staging liver fibrosis in MASLD patients in NIDDK studies\u2019 populations using liver biopsy<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f4c2f5a e-con-full e-flex e-con e-child\" data-id=\"f4c2f5a\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-da16b99 elementor-widget elementor-widget-image\" data-id=\"da16b99\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=355\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"2404\" height=\"1376\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef.png\" class=\"attachment-full size-full wp-image-354\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef.png 2404w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef-300x172.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef-1024x586.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef-768x440.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef-1536x879.png 1536w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef-2048x1172.png 2048w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef-1200x687.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzef-1400x801.png 1400w\" sizes=\"(max-width: 2404px) 100vw, 2404px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-2597928 e-con-full e-flex e-con e-child\" data-id=\"2597928\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-37b40fd elementor-widget elementor-widget-heading\" data-id=\"37b40fd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Application of LIVERFASt to Predict Steatosis in Chronic Hepatitis B Patients with Metabolic Syndrome<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-90abe18 e-con-full e-flex e-con e-child\" data-id=\"90abe18\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-51962ca elementor-widget elementor-widget-image\" data-id=\"51962ca\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=356\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"2388\" height=\"1376\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg.png\" class=\"attachment-full size-full wp-image-357\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg.png 2388w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg-300x173.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg-1024x590.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg-768x443.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg-1536x885.png 1536w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg-2048x1180.png 2048w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg-1200x691.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-tzvg-1400x807.png 1400w\" sizes=\"(max-width: 2388px) 100vw, 2388px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-bb27c20 e-con-full e-flex e-con e-child\" data-id=\"bb27c20\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-abb6367 elementor-widget elementor-widget-heading\" data-id=\"abb6367\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Comparison of the prevalence of advanced fibrosis (AF) using two combinations Liver stiffness measurement (LSM or VCTE Fibroscan) along with LiverSTAT (LST) or FIB-4 in a prospective chronic liver diseases (CLD) cohort <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3e25885 e-con-full e-flex e-con e-child\" data-id=\"3e25885\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a286c6f elementor-widget elementor-widget-image\" data-id=\"a286c6f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/fibronostics.com\/?attachment_id=359\" target=\"_blank\">\n\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"2394\" height=\"1380\" src=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu.png\" class=\"attachment-full size-full wp-image-360\" alt=\"\" srcset=\"https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu.png 2394w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu-300x173.png 300w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu-1024x590.png 1024w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu-768x443.png 768w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu-1536x885.png 1536w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu-2048x1181.png 2048w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu-1200x692.png 1200w, https:\/\/fibronostics.com\/wp-content\/uploads\/2026\/05\/SCR-20260528-uamu-1400x807.png 1400w\" sizes=\"(max-width: 2394px) 100vw, 2394px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4c9ae3a e-con-full e-flex e-con e-child\" data-id=\"4c9ae3a\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7c7df09 elementor-widget elementor-widget-heading\" data-id=\"7c7df09\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Application of LIVERFASt Biomarkers to Evaluate Longitudinal Hepatic Fibrosis and Inflammation after HCV cure<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Publications Publications Highlight Highlights Dynamics of Noninvasive Tests (NITs) \u2013 LIVERFASt, FIB-4 and Vibration-Controlled Transient Elastography (VCTE, FibroScan), During Monitoring Therapy with Resmetirom (RT) in Patients with MASH LIVERFASt Outperforms FIB-4, in Sequential Combination with Vibration-Controlled Transient Elastography (VCTE) for Identifying \u2265F3 Stages in Patients with MASLD Including Patients with Type 2 Diabetes (T2DM) Publications &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_genesis_block_theme_hide_title":false,"footnotes":""},"class_list":["post-238","page","type-page","status-publish","hentry","post","without-featured-image"],"featured_image_src":null,"featured_image_src_square":null,"_links":{"self":[{"href":"https:\/\/fibronostics.com\/index.php?rest_route=\/wp\/v2\/pages\/238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fibronostics.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fibronostics.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fibronostics.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fibronostics.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=238"}],"version-history":[{"count":0,"href":"https:\/\/fibronostics.com\/index.php?rest_route=\/wp\/v2\/pages\/238\/revisions"}],"wp:attachment":[{"href":"https:\/\/fibronostics.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}